References
- Rout P, Garlapati P, Qurie A. Granulomatosis with polyangiitis. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Available from: https://www.ncbi.nlm.nih.gov/books/NBK557827/.
- Robson JC, Grayson PC, Ponte C, Suppiah R, Craven A, et al. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for granulomatosis with polyangiitis. Ann Rheum Dis. 2022;81(3):315-20. DOI: 10.1136/annrheumdis-2021-221795.
- Webb H, Toppi J, Fairley J, Phillips D. Granulomatosis with polyangiitis: a rare but clinically important disease for the otolaryngologist. Niger J Clin Pract. 2024;27(7):819-26. DOI: 10.4103/njcp.njcp_790_23.
- Coates ML, Willcocks LC, Sivasothy P, Del Pero MM. Ear, nose, throat and airways disease in granulomatosis with polyangiitis. Rheumatology (Oxford). 2021;60(Supple 3):iii50-iii53. DOI: 10.1093/rheumatology/keab042.
- Padoan R, Campaniello D, Felicetti M, Cazzador D, Schiavon F. Ear, nose, and throat in ANCA-associated vasculitis: a comprehensive review. Vessel Plus. 2021;5:41. DOI: 10.20517/2574-1209.2021.41.
- Felicetti M, Cazzador D, Padoan R, Pendolino AL, Faccioli C, Nardello E, et al. Ear, nose and throat involvement in granulomatosis with polyangiitis: how it presents and how it determines disease severity and long-term outcomes. Clin Rheumatol. 2018;37(4):1075-83. DOI: 10.1007/s10067-018-4019-0.
- Tateyama K, Umemoto S, Iwano S, Hirano T, Suzuki M. Sinonasal manifestations of granulomatosis with polyangiitis: A retrospective analysis. Auris Nasus Larynx. 2024;51(4):625-30. DOI: 10.1016/j.anl.2024.04.002.
- Trimarchi M, Bozzolo E, Pilolli F, Bertazzoni G, Campochiaro C, Sabbadini MG, et al. Nasal mucosa narrow band imaging in granulomatosis with polyangiitis (Wegener granulomatosis): A preliminary study. Am J Rhinol Allergy. 2015;29(3):170-4. DOI: 10.2500/ajra.2015.29.4169.
- Hegazy MT, Ahmed H, Eltelety AM. ENT manifestations of Granulomatosis with polyangiitis. Vessel Plus. 2021;5:46. DOI: 10.20517/2574-1209.2021.52.
- D’Anza B, Langford CA, Sindwani R. Sinonasal imaging findings in granulomatosis with polyangiitis (Wegener granulomatosis): A systematic review. Am J Rhinol Allergy. 2017;31(1):16-21. DOI: 10.2500/ajra.2017.31.4408.
- Bossuyt X, Tervaert JWC, Arimura Y, Blockmans D, Flores-Suarez LF, Guillevin L, et al. Position paper: Revised 2017 international consensus on testing of ANCAs in granulomatosis with polyangiitis and microscopic polyangiitis. Nat Rev Rheumatol. 2017;13(11):683-92. DOI: 10.1038/nrrheum.2017.140.
- Masiak A, Zdrojewski Z, Peksa R, Smolenska Z, Czuszynska Z, Sieminska A, et al. The usefulness of histopathological examinations of non-renal biopsies in the diagnosis of granulomatosis with polyangiitis. Rheumatologia. 2017;55(5):230-6. DOI: 10.5114/ reum.2017.71638.
- Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F, et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2013;65(1):1-11. DOI: 10.1002/art.37715.
- Hoffman GS, Kerr GS, Leavitt RY, Hallahan CW, Leobovics RS, Travis WD, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med. 1992;116(6):488-98. DOI: 10.7326/0003-4819-116-6-488.
- Leavitt RY, Fauci AS, Bloch DA, Michel BA, Hunder GG, Arend WP, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener’s granulomatosis. Arthritis Rheum. 1990;33(8):1101-7. DOI: 10.1002/art.1780330807.
- Watts R, Lane S, Hanslik T, Hauser T, Hellmich B, Koldingsnes W, et al. Development and validation of a consensus methodology for the classification of the ANCA-associated vasculitides and polyarteritis nodosa for epidemiological studies. Ann Rheum Dis. 2007;66(2):222–7. DOI: 10.1136/ard.2006.054593.
- Holle JU, Laudien M, Gross WL. Clinical manifestations and treatment of Wegener’s granulomatosis. Rheum Dis Clin North Am. 2010;36(3):507-26. DOI: 10.1016/j. rdc.2010.05.008.
- McCarthy E, Mustafa M, Watts M. ANCA-negative granulomatosis with polyangiitis: a difficult diagnosis. Eur J Case Rep Intern Med. 2017;4(8):000625. DOI: 10.12890/2017_000625.
- Savige J, Pollock W, Trevisin M. What do antineutrophil cytoplasmic antibodies (ANCA) tell us? Best Pract Res Clin Rheumatol. 2005;19(2):263-76. DOI: 10.1016/j. berh.2004.10.003.
- Trimarchi M, Bondi S, Della Torre E, Terreni MR, Bussi M. Palate perforation differentiates cocaine-induced midline destructive lesions from granulomatosis with polyangiitis. Acta Otorhinolaryngol Ital. 2017;37(4):281-5. DOI: 10.14639/0392-100X-1586.
- Hellmich B, Sanchez-Alamo B, Schirmer JH, Berti A, Blockmans D, Cid MC, et al. EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update. Ann Rheum Dis. 2024;83(1):30-47. DOI: 10.1136/ard-2022-223764.
- Stone JH, Merkel PA, Spiera R, Seo P, Langford CA, Hoffman GS, et al. Rituximab versus cyclophosphamide for ANCA-associated vasculitis. N Engl J Med. 2010;363(3):221-32. DOI: 10.1056.NEJMoa0909905.
- Jones RB, Tervaert JWC, Hauser T, Luqmani R, Morgan MD, Peh CA, et al. Rituximab versus cyclophosphamide in ANCA-associated renal vasculitis. N Engl J Med. 2010;363(3):211-20. DOI: 10.1056/NEJMoa0909169.
- Walsh M, Merkel PA, Peh CA, Szpirt WM, Peuchal X, Fujimoto S, et al. Plasma exchange and glucocorticoids in severe ANCA-associated vasculitis. N Engl J Med. 2020;382(7):622-31. DOI: 10.1056/NEJMoa1803537.
- Jayne DRW, Merkel PA, Schall TJ, Bekker P; ADVOCATE Study Group. Avacopan for the treatment of ANCA-associated vasculitis. N Engl J Med. 2021;384(7):599-609. DOI: 10.1056/NEJMoa2023386.
- Schirmer JH, Sanchez-Alamo B, Hellmich B, Jayne D, Monti S, Luqmani RA, et al. Systematic literature review informing the 2022 update of the EULAR recommendations for the management of ANCA-associated vasculitis (AAV): part 1—treatment of granulomatosis with polyangiitis and microscopic polyangiitis. RMD Open. 2023;9:e003082. DOI: 10.1136/rmdopen-2023-003082.
- Guillevin L, Pagnoux C, Karras A, Khouatra C, Aumaitre O, Cohen P, et al. Rituximab versus azathioprine for maintenance in ANCA-associated vasculitis. N Engl J Med. 2014;371(19):1771-80. DOI: 10.1056/NEJMoa1404231.
- Coordes A, Loose SM, Hofmann VM, Hamilton GS 3rd, Riedel F, Menger DJ, et al. Saddle nose deformity and septal perforation in granulomatosis with polyangiitis. Clin Otolaryngol. 2018;43(1):291-9. DOI: 10.1111/coa.12977.
- Gantous A, Fernandez-Pellon Garcia RF. Nasal reconstruction in granulomatosis with polyangiitis: a two decade review. Facial Plast Surg Aesthet Med. 2023;25(1):61-7. DOI: 10.1089/fpsam.2021.0348.
- King C, Harper L, Little M. The complications of vasculitis and its treatment. Best Pract Res Clin Rheumatol. 2018;32(1):125-36. DOI: 10.1016/j.berh.2018.07.009.
- Greco A, Marinelli C, Fusconi M, Macri GF, Gallo A, De Virgilio A, et al. Clinic manifestations in granulomatosis with polyangiitis. Int J Immunopathol Pharmacol. 2016;29(2):151-9. DOI: 10.1177/0394632015617063.
- Emejuaiwe N. Treatment strategies in ANCA-associated vasculitis. Curr Rheumatol Rep. 2019;21(7):33. DOI: 10.1007/s11926-019-0835-8.